ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2 - Concepedia

Concepedia

Publication | Open Access

ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2

DOI Full Paper Access

158

Citations

24

References

2010

Year

Koji Chono, Kiyomitsu Katsumata, Toru Kontani, M. Kobayashi, Keiichi Sudo, Tomoyuki Yokota, Katsuhiro Konno, Yusuke Shimizu, Hiroshi Suzuki

Journal of Antimicrobial Chemotherapy

Abstract

ASP2151 is a novel herpes helicase-primase inhibitor that warrants further investigation for the potential treatment of both VZV and HSV infections.

References

	Year	Citations

Page 1